Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael W. Rogers currently holds 53,600 shares of Akebia Therapeutics, Inc. (AKBA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael W. Rogers has been a net seller of AKBA stock. They have purchased $0 and sold $405.9K worth of shares.
Michael W. Rogers's most recent insider trade was on Jun 17, 2026, when they sold 53,600 shares at $0.00 per share.
Michael W. Rogers serves as Executive at Akebia Therapeutics, Inc. (AKBA). They have executed 31 insider transactions totaling $405.9K over their tenure at the company.
Michael W. Rogers holds the position of Executive at Akebia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Michael W. Rogers has shown a selling trading pattern, with $0 in total purchases and $405.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael W. Rogers was on Oct 7, 2014, when they sold $188.7K worth of ACOR shares. This transaction involved 5,700 shares at $33.10 per share.
Michael W. Rogers currently owns 53,600 shares of Akebia Therapeutics, Inc. (AKBA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael W. Rogers's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael W. Rogers has 31 Form 4 filings on record as an insider at Akebia Therapeutics, Inc..
Set alerts for Michael W. Rogers and 40,000+ other insiders.